Overview
Douglas Lee is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Lee is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Virginia Mason Medical Center
John Flores is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Flores has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Splenectomy. Dr. Flores is currently accepting new patients.
The Association Of University Physicians
Scott Tykodi is an Oncologist in Seattle, Washington. Dr. Tykodi is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Adult Soft Tissue Sarcoma, and Nephrectomy. Dr. Tykodi is currently accepting new patients.
Dennis Willerford is an Oncologist and a Hematologist Oncology provider in Poulsbo, Washington. Dr. Willerford is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Waldenstrom Macroglobulinemia, Adult Immune Thrombocytopenia, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Willerford is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Lee isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Lee isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- AngiosarcomaDr. Lee isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Lee isAdvanced. Learn about Breast Cancer.
- Chromophobe Renal Cell Carcinoma
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Clear Cell SarcomaDr. Lee isAdvanced. Learn about Clear Cell Sarcoma.
- Experienced
- Acute Mountain SicknessDr. Lee isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Lee isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Lee isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaDr. Lee isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Lee isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer